Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pioglitazone hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet |
Has precise active ingredient |
True |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet |
Has precise active ingredient |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet |
Has precise active ingredient |
True |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glimepiride 2 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glimepiride 4 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet |
Has precise active ingredient |
True |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 45 mg oral tablet |
Has precise active ingredient |
True |
Pioglitazone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |